Name: Recombinant Human B Cell Maturation Antigen (BCMA)
Price: Inquiry

- Overview
  - BCMA, also known as TNFRSF17, is a type III membrane protein and member of the TNF receptor superfamily, which are critically involved in the maintenance of homeostasis of the immune system (1). BCMA expression has been found in immune organs and mature B cell lines. Although some expression has been observed at the cell surface, BCMA appears to be localized to the Golgi compartment (2). Both BAFF and APRIL are ligands for BCMA (4-5). BCMA/BAFF binding induces B cell development and survival, activates NF-κB and c-jun N-terminal kinase, and is involved in B cell associated autoimmune diseases. The binding of BCMA to APRIL has been shown to stimulate IgM production in peripheral blood B cells and increase the survival of cultured B cells (4). This data suggests that BCMA may play an important role in B cell development, function and regulation. BCMA also binds B-lymphocyte stimulator (BLyS) (6).
    
    Please contact us at for specific academic pricing.
- Properties
  - Protein Name
    
    B-cell maturation protein, BCM, BCMA, CD269, TNFRSF17
    
    Type
    
    Recombinant Proteins
    
    Reactivity
    
    Human
    
    Purification
    
    >95% by SDS-PAGE and analyzed by silver stain.
    
    Formulation
    
    This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives.
    
    Storage
    
    This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
    
    Activity
    
    Biological Activity of Human BCMA was determined by its ability to inhibit APRIL-mediated proliferation of anti-IgM stimulated mouse B cells. The expected ED50 for this effect is typically 0.01 - 0.04 μg/ml in the presence of 100 ng/ml of rhAPRIL.
    
    More Information
    
    UniProt
    
    Q02223
    
    Gene ID
    
    608
    
    * For Research Use Only. Not for use in diagnostic/therapeutics procedures.
- Applications
  - Application
    
    ELISA
    
    Application Description
    
    This can be used as capture antibody. The biological activity of Human BCMA was determined by its ability to inhibit APRIL-mediated proliferation of anti-IgM stimulated mouse B cells. The expected ED50 for this effect is typically 0.01 - 0.04 μg/ml in the presence of 100 ng/ml of rhAPRIL.

Recombinant Human B Cell Maturation Antigen (BCMA)

Recombinant Human B Cell Maturation Antigen (BCMA)

More Information

We Also Recommend

Recombinant Human Erythropoietin/EPO (C-6His)

Recombinant Human Granulocyte Colony-Stimulating Factor/G-CSF

Recombinant Human Interferon a2B Variant (Arg46)/IFN-a2B